Construction Industry News
India has recorded more than 160 cases of the new Covid variant according to data from INSACOG, a forum created under the Ministry of Health and Family Welfare. INSACOG data showed that 145 Covid cases recorded in the country in December had the presence of JN.1, while 17 cases of this type were detected in November.
The World Health Organization (WHO) has classified JN.1 as a separate "variant of concern" given its rapid spread. However, the UN body said it poses a "low" health risk.
The Center has asked states and Union Territories to maintain constant vigilance amid a rise in Covid cases and the detection of the JN.1 sub-variant in the country.
India has so far reported 162 cases of the JN.1 subvariant of Covid-19.
Among Indian states, Kerala has seen a significant increase in JN.1 sub-variant with 83, followed by Gujarat with 34, Karnataka with 8, Maharashtra with 10, Rajasthan with 5, Tamil Nadu with 4, Telangana with 2 and Delhi with 1. respectively.
India reported 145 Covid cases of the JN.1 subvariant in December, while 17 such cases were detected in November.
Five more people tested positive in Odisha. With this, the number of Covid cases in the state increased to 13 by December 2023.
Maharashtra recorded 129 new Covid-19 cases. The number of patients infected with the JN.1 variant remains at 10.
Since January 1, 2023, Maharashtra has recorded 137 COVID-19 deaths. 70.80% of these deaths occurred in people over 60 years of age, 84% of those who died presented comorbidities, while 16% did not present comorbidities.
Karnataka on Friday reported 173 new Covid-19 cases and two coronavirus-related deaths in the last 24 hours.
Dr Soumya Swaminathan, former director general of the Indian Council of Medical Research (ICMR), warned that the JN.1 Covid-19 variant is more transmissible and contagious compared to other variants. However, Swaminathan also assured: “The risk to public health remains low in the sense that we all now have immunity.”
Andhra Pradesh reported a rise in Covid cases, with 82 infections reported since December 20, according to the Deccan Herald report.
Scientists around the world are now turning to fungi in the fight against Covid-19. According to DD News, a study led by Prof. Ashis K Mukherjee and a team of researchers from the Institute of Advanced Studies in Science and Technology (IASST) delved into the importance of edible mushrooms and their bioactive compounds in reducing associated complications with COVID-19. -19 and other viral infections.
